Clinical Trial Update: Remegal Different Doses in Patients With Refractory Partial Seizures [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different doses of Remegal in patients with refractory partial seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• Remegal

Snippet

Sponsor: Valexfarm | Conditions: Drug Safety, Normal Drug Tolerance | Phase 2 | Status: COMPLETED